ArticleEMBO molecular medicine2010

Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.

Stephen J McConoughey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.